RadNet Inc. (NASDAQ:RDNT) Director John V. Crues sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $10.08, for a total value of $201,600.00. Following the transaction, the director now owns 563,781 shares in the company, valued at approximately $5,682,912.48. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

RadNet Inc. (RDNT) traded down $0.40 during trading on Friday, hitting $10.10. The company had a trading volume of 283,782 shares, compared to its average volume of 247,625. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market cap of $500.05, a P/E ratio of 35.00, a P/E/G ratio of 3.53 and a beta of 0.83. RadNet Inc. has a 52 week low of $5.25 and a 52 week high of $11.90.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, hitting the consensus estimate of $0.12. The company had revenue of $227.60 million for the quarter, compared to the consensus estimate of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The firm’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.11 EPS. research analysts predict that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. Airain ltd purchased a new stake in shares of RadNet in the 2nd quarter worth approximately $100,000. Campbell & CO Investment Adviser LLC purchased a new stake in RadNet during the 2nd quarter valued at $102,000. National Planning Corp boosted its stake in RadNet by 9.8% during the 2nd quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock valued at $132,000 after purchasing an additional 1,500 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in RadNet during the 3rd quarter valued at $195,000. Finally, Prudential Financial Inc. boosted its stake in RadNet by 15.2% during the 2nd quarter. Prudential Financial Inc. now owns 20,410 shares of the medical research company’s stock valued at $158,000 after purchasing an additional 2,700 shares during the last quarter. Institutional investors own 53.31% of the company’s stock.

Several analysts recently weighed in on the company. Zacks Investment Research downgraded RadNet from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. TheStreet upgraded RadNet from a “c” rating to a “b-” rating in a research note on Thursday, August 24th. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th. Finally, Jefferies Group upgraded RadNet from a “hold” rating to a “buy” rating and upped their price target for the stock from $7.00 to $12.00 in a research note on Tuesday, August 22nd.

TRADEMARK VIOLATION WARNING: This story was reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/12/02/radnet-inc-rdnt-director-john-v-crues-sells-20000-shares.html.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.